The ROS–Nrf2–NLRP3 network thus highlights the dual nature of ROS in PD: transient, regulated increase can trigger protective antioxidant responses, whereas persistent ROS elevation fuels inflammasome activity and neurodegeneration. This evidence concerns the gene NLRP3 and Parkinson disease.